Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine

Hypertension

Volumn 27, Issue 4, 1996, Pages 933-938

  Rongen, Gerard A ^a   Lenders, Jacques W M ^a   Lambrou, Jorgo ^a   Willemsen, Jacques J ^a   Van Belle, Herman ^b   Thien, Theo ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

adenosine; norepinephrine; nucleosides; receptors, presynaptic

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; DRAFLAZINE; NORADRENALIN; TRITIUM;

ADULT; ARTICLE; DOSE RESPONSE; FOREARM BLOOD FLOW; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; NORMAL HUMAN; NUCLEOSIDE TRANSPORT; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SYMPATHETIC NERVE; VASCULAR RESISTANCE;

EID: 0029914871     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.4.933     Document Type: Article

References (33)

1. Burnstock G, Sneddon P. Evidence for ATP and noradrenaline as cotransmitters in sympathetic nerves. Clin Sci. 1985;68(suppl 10): 89s-92s.
2. Pearson J, Carleton J, Gordon J. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J. 1980;190:421-429.
3. Juul B, Lüscher ME. Aalkjaer C, Plesner L. Nucleotide hydrolytic activity of isolated intact mesenteric small arteries. Biochim Biophys Acta. 1991;1067:201-207.
4. Welford LA, Cusack NJ, Hourani SMO. The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoccptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol. 1987;141:123-130.
5. Van Belle H. Nudeoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res. 1993;27:68-76.
6. 3H]norepinephrine release from perfused mesenleric arteries of SHR and renal hypertensive rats. Eur J Pharmacol. 1983;87:349-352.
7. von Kugelgen I, Spath L, Starke K. Stable adenine nucleotides inhibit [H-3]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine Al-receptors. Naunyn Schmiedebergs Arch Pharmacol. 1992;346:187-196.
8. Wennmalm M, Fredholm BB, Hedqvist P. Adenosine as a modulator of sympathetic nerve-stimulation-induced release of noradrenaline from the isolated rabbit heart. Acta Physiol Scand. 1988;132:487-494.
9. Taddei S, Pedrinelli R, Salvetti A. Sympathetic nervous system-dependent vasoconstriction in humans: evidence for mechanistic role of endogenous purine compounds. Circulation, 1990;82:2061-2067.
10. Burnstock G, Kennedy C. A dual function for adenosine 5′-triphosphate in the regulation of vascular tone: excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res. 1985;58:319-330.
11. Smits P, Lenders JW, Willemsen JJ, Thien T. Adenosine attenuates the response to sympathetic stimuli in humans. Hypertension. 1991;18:216-223.
12. Biaggioni I, Olafsson B, Rohertson RM, Hollister AS, Rohertson D. Cardiovascular and respiratory effects of adenosine in conscious man: evidence for chemoreceptor activation. Circ Res. 1987;61:779-786.
13. Engelstein ED, Lerman BE, Somers VK, Rea RF. Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity. Circulation. 1994;90:2919-2926.
14. Rongen GA, Smits P, Ver Donck K, Willemsen JJ, de Abreu RA, Van Belle H, Thien T. Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans: implications for its future role in cardioprotection. J Clin Invest. 1995;95:658-668.
15. Smits P, Lenders JW, Thien T. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther. 1990;48:410-418.
16. Myers HA, Honig CR. Influence of initial resistance on magnitude of response to vasomotor stimuli. Am J Physiol. 1969;216:1429-1436.
17. Smits P, Hoffmann H, Thien T, Houben H, van't Laar A. Hemodynamic and humoral effects of coffee after beta-1-selective and nonselective beta-blockade. Clin Pharmaacol Ther. 1983;34:153-158.
18. Grossman E, Chang PC, Huffman A, Tamrat M, Kopin IJ, Goldstein DS. Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion. Am J Physiol. 1991;260:R946-R952.
19. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988;11:3-20.
20. Chang PC, Kriek E, van Brummelen P. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. J Hypertens. 1994;12:179-190.
21. Van Belle H, Verheyen W, Donck KV, Janssen PAJ, Robertson JIS. Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor. J Cardiovasc Pharmacol. 1992;20:173-178.
22. Smits P, Schnuten J, Thien T. Respiratory stimulant effects of adenosine in man after caffeine and enprofylline. Br J Clin Pharmacol. 1987;24:816-819.
23. Smits P, Boekema P, Thien T, de Abreu R, van't Laar A. Evidence for an antagonism between caffeine and adenosine in the cardiovascular system in man. J Cardiovasc Pharmacol. 1987;10:136-143.
24. Biaggioni I, Killian TJ, Mosqueda Garcia R, Robertson RM, Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation. 1991;83:1668-1675.
25. Rongen GA, Smits P, Bootsma G, Ver Donck K, de Vries A, Thien T. High-grade nucleoside transport inhibition stimulates ventilation in humans. J Clin Pharmacol. 1995;35:357-361.
26. Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation. 1991;83:774-777.
27. Taddei S, Salvetti A, Pedrinelli R. Persistence of synipathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients. Circulation. 1989;80:485-491.
28. Deussen A, Moser G, Schrader J. Contribution of coronary endothelial cells to cardiac adenosine production, Pflugers Arch. 1986;406:608-614.
29. Schutz W, Schrader J, Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol. 1981;240:H963-H970.
30. Borst MM, Schrader J. Adenine nucleotidc release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res. 1991;68:797-806.
31. Burnstock G, Griffith SG, Sneddon P. Autonomic nerves in the precapillary vessel wall. J Cardiovasc Pharmacol. 1984;6(suppl 2):S344-S353.
32. Costa F, Biaggioni I. Role of adenosine in the sympathetic activation produced by isometric exercise in humans. J Clin Invest. 1994;93:1654-1660.
33. Biaggioni I. Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension. 1992;20:457-465.